¡Ya estamos en ! Descubre más
icono de ZYXI

Zynex
ZYXI

Excluida de cotización

ZYXI dejó de cotizar en bolsa el 23 de diciembre de 2025.

Volver al ranking
 

Acerca de: Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Empleados: 1,000

Salud Distribución médica

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%
Neutral
PRNewsWire
hace 11 meses
Zynex Financial Restructuring Puts Company on Path to Long-Term Success
ENGLEWOOD, Colo. , Dec. 16, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management and rehabilitation today announced it has voluntarily entered into a Chapter 11 court-supervised financial restructuring with the support of new financing from the Company's lenders.
Zynex Financial Restructuring Puts Company on Path to Long-Term Success
Neutral
Seeking Alpha
hace 11 meses
Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript
Zynex, Inc. ( ZYXI ) Q3 2025 Earnings Call November 18, 2025 9:00 AM EST Company Participants Vikram Bajaj - Chief Financial Officer Steven Dyson - CEO & Director Presentation Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Zynex Third Quarter 2025 Earnings Conference Call.
Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript
Neutral
PRNewsWire
hace 11 meses
Zynex Reports Third Quarter 2025 Financial Results
ENGLEWOOD, Colo. , Nov. 17, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, and rehabilitation, today reported its financial and operational results for the third quarter ended September 30, 2025.
Zynex Reports Third Quarter 2025 Financial Results
Neutral
Proactive Investors
hace 12 meses
Zynex taps adviser Province, forms special board committee to review strategic options
Zynex Inc (NASDAQ:ZYXI) said on Friday it has hired financial advisory firm Province LLC and formed a special board committee to evaluate a range of strategic alternatives. The company said Province will assist in reviewing options that include potential capital-raising, recapitalization and restructuring strategies.
Zynex taps adviser Province, forms special board committee to review strategic options
Neutral
PRNewsWire
hace 12 meses
Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee
ENGLEWOOD, Colo. , Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management and rehabilitation, today announced a series of strategic initiatives aimed at positioning Zynex for long-term success.
Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee
Neutral
PRNewsWire
hace 12 meses
Zynex Sets Third Quarter 2025 Earnings Call
ENGLEWOOD, Colo. , Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management and rehabilitation, will hold a conference call on Tuesday, November 18, 2025 at 9:00 AM Eastern Time to discuss its financial results for the third quarter ended September 30, 2025.
Zynex Sets Third Quarter 2025 Earnings Call
Positivo
Proactive Investors
el año pasado
Zynex appoints industry veteran Bret Wise to its Board, will also serve as Audit Committee chair
Zynex Inc (NASDAQ:ZYXI) announced the appointment of Bret Wise to its Board of Directors. He will also serve as chair of the Audit Committee.
Zynex appoints industry veteran Bret Wise to its Board, will also serve as Audit Committee chair
Neutral
PRNewsWire
el año pasado
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
ENGLEWOOD, Colo. , Oct. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of Bret Wise to its Board of Directors.
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
Neutral
GlobeNewsWire
el año pasado
ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Sept. 27, 2025 (GLOBE NEWSWIRE) -- What's Happening: Bragar Eagel & Squire, P.C.
ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Neutral
GlobeNewsWire
el año pasado
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C.
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Ver rankings de noticias
Gráficos de precios implementados con Lightweight Charts™